| Date | Title | Description |
| 01.07.2025 | CHOSA extends the timeline for biopsy collection prior to publication from the SPLENDOUR study | CHOSA extends the timeline for biopsy collection prior to publication from the SPLENDOUR study
Tue, Jul 01, 2025 16:19 CET Report this content
The English text is an unofficial translation. In case of any discrepancies between the Swedish t... |
| 26.03.2025 | CHOSA to Unveil Predictive Data for Cisplatin Response in Lung Cancer at end Q2 2025 – Advancing Precision Medicine for the World’s Most Widely Used Cancer Drug | CHOSA to Unveil Predictive Data for Cisplatin Response in Lung Cancer at end Q2 2025 – Advancing Precision Medicine for the World’s Most Widely Used Cancer Drug
Wed, Mar 26, 2025 14:11 CET Report this content
The English text is an unoffici... |
| 13.05.2024 | Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK | BURLINGTON, Mass., May 13, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further i... |
| 11.03.2024 | NANOSTRING TECHNOLOGIES, INC. European UPC Court of Appeal overturns injunction against NanoString’s CosMx products. NanoString will immediately resume sales in 16 EU member countries. | [NANOSTRING TECHNOLOGIES, INC.]
European UPC Court of Appeal overturns injunction against NanoString’s CosMx products. NanoString will immediately resume sales in 16 EU member countries.
*View in browser* *NANOSTRING TECHNOLOGIES, INC.*
Pre... |
| 07.08.2023 | Biotech Firm 10X Genomics Is Using Tech To Transform Biology and ‘Advance Human Health’ For All People | 10X Genomics uses technology such as AI to explore and advance spatial biology. Digital Creative Associates |
| 07.12.2022 | NanoString Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform | Products Represent the Highest Plex In Situ Imager and the First Cloud-Based Data Analysis Suite for Spatial Biology
NanoString Technologies, a leading provider of life science tools for discovery and translational research, announced the f... |
| 13.10.2022 | NanoString and Visiopharm Announce Collaboration to Co-develop Integrated Workflows for GeoMx and AtoMx Spatial Biology Solutions | Collaboration to unify NanoString’s best-in-class spatial biology platforms with Visiopharm’s AI-driven image analysis capabilities to enable integrated end-to-end workflows for translational research studies.
NanoString Technologies, a lea... |
| 18.04.2022 | Tech Moves: Esper names CFO; Streem founder steps down; Nanostring adds board member | David Barclay. (Esper Photo)
— David Barclay, former chief financial officer for DigniFi and Xevo, joined Esper as CFO.
Esper is a Seattle-based startup that sells software to remotely manage IoT devices. Founded in 2018, the startup aims t... |
| 09.11.2021 | NanoString Releases High-Resolution FFPE Tissue Dataset Generated Using New CosMx Spatial Molecular Imager | NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the first public release of data generated by the CosMx™ Spatial Molecular Imager (SMI). The da... |
| 02.09.2021 | NanoString Presents: Advancing Science – A Virtual Immunology Conference: September 14, 2021 (*September 15, 2021, Asia-Pacific) | The Virtual Immunology Conference is the premier event to learn and discuss novel advances in immunology research.
SEATTLE (PRWEB) September 02, 2021
NanoString Technologies, a leading provider of life science tools for translational resear... |
| 01.04.2021 | SITC Announces Two Spatial Technology Awards for Early Career Scientists to Advance Cancer Immunotherapy Research | Society for Immunotherapy of Cancer “SITC views these two unique technology awards as an investment in the future of our field that we hope will lead to innovative and cutting-edge immunotherapy approaches and ultimately better outcomes for... |
| 31.03.2021 | NANOSTRING TECHNOLOGIES, INC.
NanoString :'s GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications | NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that two peer-reviewed publications using the GeoMx® Digital Spatial Profiler have been publish... |
| 18.02.2021 | NanoString to Host the 3rd Annual “Spatial Genomics Summit,” February 23-24, 2021 | NanoString to Host the 3rd Annual “Spatial Genomics Summit,” February 23-24, 2021.
SEATTLE (PRWEB) February 18, 2021
NanoString Technologies to hold the 3rd Annual “Spatial Genomics Summit” virtually on February 23, 2021 (February 24 – Asia... |
| 27.07.2016 | BioMed Realty opening new biotech startup space in lab-starved Seattle | BioMed Realty recently finished The Labs @ 201 Elliott, a startup space for biotech companies. Credit: BioMed Realty.
Startup, co-working and incubator spaces are proliferating throughout the Puget Sound region. But Seattle isn’t just a tec... |
| 27.01.2015 | DFJ Grows Seattle Footprint With New Entrepreneur in Residence | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Venture capital giant Draper Fisher Jurvetson (DFJ) has stationed its first entrepreneur in residence in Seattle.
Seattle native Bryan Hale, 32, will work with Seattle-based p... |
| 27.06.2013 | Seattle Roundup: NanoString IPOs, Socrata Scores $18M, and More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
The second quarter is wrapping up with a less-than-stellar IPO for NanoString Technologies, a major raise by government data company Socrata, a DARPA grant for a UW team makin... |
| 20.05.2013 | Genomics startup NanoString files for IPO in spite of consistent losses | NanoString is a genomics company with special technology for helping cancer researchers that has just filed an S-1, declaring to the SEC (and the reading world) its intention to go public.
The company’s technology uses small amounts of tiss... |
| 20.05.2013 | Genomics startup NanoString files for IPO in spite of consistent losses | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
NanoString is a genomics company with special tec... |
| 03.12.2012 | NanoString lands $15.3M for genetic analysis system | NanoString Technologies continues to rake in new capital, announcing today that it has raised $15.3 million from Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment Management Group. Existing investors, including C... |
| 03.12.2012 | Genetic analysis company NanoString will use $15.3M for first launch in molecular diagnostics | The $15.3 million came from previous investors Clarus Ventures, Draper Fisher Jurvetson, OVP Venture Partners, GE healthymagination Fund, BioMed Ventures and Henri Termeer, and new investors Morgan Stanley Expansion Capital and AllianceBern... |
| 03.12.2012 | NanoString Technologies Completes $15.3M Series E Funding | NanoString Technologies, Inc., a Seattle, WA-based provider of life science tools for translational research and developer of molecular diagnostic products, has completed a $15.3m Series E funding.
Backers include new investors Morgan Stanl... |
| 03.12.2012 | NanoString Technologies Completes $15.3M Series E |
SEATTLE, WA, Privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced the completion of a $15.3 million Series E Preferred.
>> Click here for more fund... |
| 29.05.2012 | NanoString Nabs Ex-Seattle Genetics Exec to Lead Diagnostic Push | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Seattle-based NanoString Technologies sees itself growing from a research tool company into a more diversified player with diagnostic tests that enable more personalized cance... |
| 15.05.2012 | GE $250M fund manager: We have a lot of dry powder, looking to invest | How much of the $250 million have you invested?
For competitive reasons, we don’t disclose that, but we have a lot of dry powder. We’re more opportunity short than capital short, which is a great place to be in in this environment given som... |
| 06.04.2012 | NanoString Technologies Receives $15M in Debt Financing | NanoString Technologies, Inc., a Seattle, WA-based provider of life sciences tools for translational research and developer of molecular diagnostics, has received $15m in debt financing.
The financing, which was awarded from both Oxford Fin... |
| 08.12.2011 | NanoString Nails Breast Cancer Study, Challenging Genomic Health | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Seattle-based NanoString Technologies has made a big bet that the future of the company depends on turning its genetic analysis research tool into a diagnostic workhorse. Toda... |
| 07.11.2011 | NanoString Secures $20M Series D |
Provider of life science tools for translational research and developer of molecular diagnostics, closed $20M in a Series D round. New investors include GE, BioMed Ventures and Henri Termeer. All previous investors also participated inclu... |
| 07.11.2011 | NanoString Technologies Closes $20M Series D Equity Financing | NanoString Technologies, Inc., a Seattle, WA-based provider of life science tools for translational research and developer of molecular diagnostics, has closed a $20m Series D equity financing.
Backers include new investors GE, BioMed Ventu... |
| 07.11.2011 | NanoString lands $20 million | NanoString Technologies, a maker of genomic analysis tools, has raised $20 million in venture capital financing in a deal led by GE, BioMed Ventures and former Genzyme CEO Henri Termeer. Existing investors Clarus Ventures, Draper Fisher Jur... |
| 24.03.2009 | Nanostring CEO Perry Fell Departs | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Nanostring Technologies CEO Perry Fell has resigned as CEO, and has been replaced on an acting basis by chief financial officer Wayne Burns. The Seattle-based company, which m... |
| 26.06.2007 | NanoString wraps up $8.5M for molecular bar codes | NanoString, a Seattle nanotech company working on tiny tags that it says will allow it to identify and count individual molecules in a solution, has raised $8.5 million in a second funding round, VentureWire reports (subscription required).... |
| - | GE $250M fund manager: We have a lot of dry powder, looking to invest | Startups, listen up.
GE’s nearly two-and-a-half-year-old, $250 million Healthymagination Fund still has a “lot of dry powder” and executives are looking for promising startups to invest in.
Noah Lewis, managing director of the Healthymagina... |
| - | Genetic analysis company NanoString will use $15.3M for first launch in molecular diagnostics | A company with roots in developing tools for translational research has raised $15.3 million to execute the first step of its pursuit of market share in diagnostics.
NanoString Technologies Inc. said the round will help fund the U.S. regula... |
